Type 2 diabetes is one of the most common long-term health conditions in the world.
It affects hundreds of millions of people and occurs when the body cannot use insulin properly or does not produce enough insulin to keep blood sugar levels within a healthy range.
Over time, high blood sugar can damage blood vessels and organs, increasing the risk of heart disease, stroke, kidney disease, vision problems, and nerve damage. Because of these risks, keeping blood sugar under control is one of the most important goals of diabetes treatment.
For many people with type 2 diabetes, the first medicine prescribed is metformin. Metformin has been used for decades and is considered the standard starting treatment because it is effective, affordable, and generally safe.
However, diabetes often becomes more difficult to manage over time, and many patients eventually need an additional medication to help control their blood sugar levels.
To better understand which medicines work best when added to metformin, researchers from The GRADE Study carried out one of the largest and most detailed diabetes treatment studies ever conducted.
Their goal was to compare four commonly used diabetes medications and determine which one was most effective at helping people maintain healthy blood sugar levels over the long term.
The study included 5,047 adults with type 2 diabetes from a wide range of racial and ethnic backgrounds across the United States. All participants were already taking metformin when they entered the study. The researchers randomly assigned them to one of four treatment groups. Each group received a different medication in addition to metformin.
The four medicines studied were sitagliptin, liraglutide, glimepiride, and insulin glargine U-100. Although all of these treatments help lower blood sugar, they work in different ways. Sitagliptin helps the body increase insulin production after meals.
Liraglutide helps the body release insulin, slows stomach emptying, and can also reduce appetite. Glimepiride encourages the pancreas to produce more insulin. Insulin glargine is a long-acting form of insulin that provides steady blood sugar control throughout the day and night.
The participants were followed for an average of four years. During this time, researchers regularly measured blood sugar levels to see how long each treatment could keep diabetes under control.
The results showed that liraglutide and insulin glargine performed better than the other two medications. People taking these treatments were able to maintain their target blood sugar levels for a longer period of time.
On average, they kept their blood sugar under control for about six months longer than people taking sitagliptin, which turned out to be the least effective option in the study.
Glimepiride produced somewhat better results than sitagliptin, but it was still not as effective as liraglutide or insulin glargine. This finding provides doctors with valuable information when deciding which medication to prescribe after metformin alone is no longer enough.
One important finding was that the results were remarkably similar across different groups of people. The effectiveness of the medications did not appear to depend on age, sex, race, or ethnicity. This suggests that the findings may apply broadly to many people living with type 2 diabetes.
The researchers also examined heart health, which is especially important because cardiovascular disease is one of the leading causes of illness and death among people with diabetes.
Among all four treatment groups, participants taking liraglutide had the lowest risk of developing cardiovascular problems during the study period. This additional benefit may make liraglutide an attractive option for some patients, especially those who are already at increased risk of heart disease.
Despite these encouraging results, the study also highlighted how challenging diabetes management can be. Even though some treatments worked better than others, none of them provided a perfect solution.
Nearly three-quarters of participants were unable to maintain their target blood sugar levels throughout the entire four-year study period. This finding shows that many people with type 2 diabetes continue to face difficulties controlling their condition, even when receiving modern treatments.
The researchers believe these results emphasize the need for better treatment strategies and new therapies. While current medications can help many patients, there is still significant room for improvement. Future research may lead to treatments that provide longer-lasting blood sugar control and further reduce the risk of complications.
This large study gives patients and healthcare providers important evidence to support treatment decisions. Understanding the strengths and limitations of different medications can help people with diabetes choose the approach that best fits their health needs and personal circumstances.
The study was led by Dr. Henry Burch and colleagues and was published in The New England Journal of Medicine. The findings provide one of the clearest comparisons so far of commonly prescribed diabetes medications used alongside metformin.
As researchers continue searching for better ways to treat diabetes, studies like this bring doctors and patients one step closer to more effective long-term care.
If you care about diabetes, please read studies about bananas and diabetes, and honey could help control blood sugar.
For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and plant-based protein foods may help reverse type 2 diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
